Molecular characterization of vancomycin-resistant enterococci from clinical and surveillance specimens

Infection Control and Hospital Epidemiology

Volumn 27, Issue 10, 2006, Pages 1076-1080

  Huh, Ji Young ^a   Lee, Wee Gyo ^b,c   Jin, Hye Young ^b  

^a Seoul National University College of Medicine   (South Korea)

^b Ajou University School of Medicine   (South Korea)

^c Ajou University Medical Center   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BACTERIAL COLONIZATION; BACTERIAL INFECTION; CONTROLLED STUDY; GENETIC VARIABILITY; HOSPITAL ADMISSION; INTENSIVE CARE UNIT; INTESTINE FLORA; MOLECULAR BIOLOGY; NONHUMAN; PULSED FIELD GEL ELECTROPHORESIS; SOUTH KOREA; TEACHING HOSPITAL; VANCOMYCIN RESISTANT ENTEROCOCCUS;

CARRIER STATE; ELECTROPHORESIS, GEL, PULSED-FIELD; ENTEROCOCCUS; FEMALE; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; INTENSIVE CARE UNITS; INTESTINES; KOREA; LENGTH OF STAY; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS; VANCOMYCIN RESISTANCE;

EID: 33750554305     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/507961     Document Type: Article

References (20)

1. Klare I, Konstabel C, Badstubner D, Werner G, Witte W. Occurrence and spread of antibiotic resistances in Enterococcus faecium. Int J Food Microbiol 2003; 88:269-290.
2. Cetinkaya Y, Falk P, Mayhall CG. Vancomycin-resistant enterococci. Clin Microbiol Rev 2000; 13:686-707.
3. Malathum K, Murray BE. Vancomycin-resistant enterococci: recent advances in genetics, epidemiology and therapeutic options. Drug Resist Updat 1999; 2:224-243.
4. Woodford N, Adebiyi AM, Palepou MF, Cookson BD. Diversity of VanA glycopeptide resistance elements in enterococci from humans and non-human sources. Antimicrob Agents Chemother 1998; 42:502-508.
5. Simonsen GS, Myhre MR, Dahl KH, Olsvik Ø, Sundsfjord A. Typeability of Tn1546-like elements in vancomycin-resistant enterococci using long-range PCRs and specific analysis of polymorphic regions. Microb Drug Resist 2000; 6:49-57.
6. Schouten MA, Willems RJ, Kraak WA, Top J, Hoogkamp-Korstanje JA, Voss A. Molecular analysis of Tn1546-like elements in vancomycin-resistant enterococci isolated from patients in Europe shows geographic transposon type clustering. Antimicrob Agents Chemother 2001; 45:986-989.
7. Stobberingh E, van den Bogaard A, London N, Driessen C, Top J, Willems R. Enterococci with glycopeptide resistance in turkeys, turkey farmers, turkey slaughterers, and (sub)urban residents in the south of The Netherlands: evidence for transmission of vancomycin resistance from animals to humans? Antimicrob Agents Chemother 1999; 43:2215-2221.
8. Shankar V, Baghdayan AS, Huycke MM, Lindahl G, Gilmore MS. Infection-derived Enterococcus faecalis strains are enriched in esp, a gene encoding a novel surface protein. Infect Immun 1999; 67:193-200.
9. Eaton TJ, Gasson MJ. A variant enterococcal surface protein Esp(fm) in Enterococcus faecium; distribution among food, commensal, medical, and environmental isolates. FEMS Microbiol Lett 2002; 216:269-275.
10. Patel R. Clinical impact of vancomycin-resistant enterococci. J Antimicrob Chemother 2003; 51(Suppl 3):iii13-21.
11. Arthur M, Molinas C, Depardieu F, Courvalin P. Characterization of Tn1546, a Tn3-related transposon conferring glycopeptide resistance by synthesis of depsipeptide peptidoglycan precursors in Enterococcus faecium BM4147. J Bacteriol 1993; 175:117-127.
12. Lee WG, Jernigan JA, Rasheed JK, Anderson GJ, Tenover FC. Possible horizontal transfer of the vanB2 gene among genetically diverse strains of vancomycin-resistant Enterococcus faecium in a Korean hospital. J Clin Microbiol 2001; 39:1165-1168.
13. Tenover FC, Arbeit RD, Goering RV, et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 1995; 33:2233-2239.
14. Leavis H, Top J, Shankar N, et al. A novel putative enterococcal pathogenicity island linked to the esp virulence gene of Enterococcus faecium and associated with epidemicity. J Bacteriol 2004; 186:672-682.
15. Gardiner D, Murphey S, Ossman E, Jungkind D. Prevalence and acquisition of vancomycin-resistant enterococci in a medical intensive care unit. Infect Control Hosp Epidemiol 2002; 23:466-468.
16. Warren DK, Kollef MH, Seiler SM, Fridkin SK, Fraser VJ. The epidemiology of vancomycin-resistant enterococcus colonization in a medical intensive care unit. Infect Control Hosp Epidemiol 2003; 24:257-263.
17. Henning KJ, Delencastre H, Eagan J, et al. Vancomycin-resistant Enterococcus faecium on a pediatric oncology ward: duration of stool shedding and incidence of clinical infection. Pediatr Infect Dis J 1996; 15:848-854.
18. Patel R, Allen SL, Manahan JM, et al. Natural history of vancomycin-resistant enterococcal colonization in liver and kidney transplant recipients. Liver Transpl 2001; 7:27-31.
19. Shankar N, Lockatell CV, Baghdayan AS, Drachenberg C, Gilmore MS, Johnson DE. Role of Enterococcus faecalis surface protein Esp in the pathogenesis of ascending urinary tract infection. Infect Immun 2001; 69:4366-4372.
20. Willems RJ, Homan W, Top J, et al. Variant esp gene as a marker of a distinct genetic lineage of vancomycin-resistant Enterococcus faecium spreading in hospitals. Lancet 2001; 357:853-855.